TRACHITOL

This brand name is authorized in Estonia, Malta, Netherlands

Active ingredients

The drug TRACHITOL contains a combination of these active pharmaceutical ingredients (APIs):

1 Lidocaine UNII 98PI200987 - LIDOCAINE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. Read about Lidocaine

2 Propyl parahydroxybenzoate UNII Z8IX2SC1OH - PROPYLPARABEN

Read about Propyl hydroxybenzoate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R02AD	Anesthetics, local	R Respiratory system → R02 Throat preparations → R02A Throat preparations
Discover more medicines within R02AD

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1031410
Country: MT	Medicines Authority	Identifier(s): MA048/00202
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 90948